5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor

Clinical trial NCT02632370 · COMPLETED

Trial details

NCT number: NCT02632370
Sponsor: Constantinos Hadjipanayis
Status: COMPLETED
Study type: OBSERVATIONAL

Malignant Gliomas

Start date: 2016-05-01
Primary completion: 2018-12-31
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.